Needham Maintains Buy on OrthoPediatrics, Raises Price Target to $35

Benzinga Newsdesk www.benzinga.com Positive 66.7%

Neg 0% Neu 0% Pos 66.7%

Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $30 to $35.